FDA Approves 23 E-Cigarette Products in 2022

Feb.01.2023
FDA Approves 23 E-Cigarette Products in 2022
FDA has made progress in improving public health by tightening regulations and approving PMTA applications for tobacco products.

On January 31, Brian King, the director of the Center for Tobacco Products (CTP) at the US Food and Drug Administration (FDA), issued a public letter. In the letter, it was stated that significant progress was made in improving public health by the CTP in 2022 through proposing regulations, reviewing applications for new tobacco products prior to legal sales (PMTA), enforcing compliance, investigating and holding accountable companies that broke the law, and educating the public about the risks of tobacco products. Currently, preparations are underway for 2023.


So far, the FDA has received over 6.7 million applications for e-cigarette products, but has only approved 23 of them. Among them, 3 were approved in 2021 and 20 were approved in 2022, all of which were tobacco flavors.


According to a list, there are 9 products from R.J, a subsidiary of British American Tobacco (BAT), 8 products from Logic, a subsidiary of Japan Tobacco, and 6 products from NJOY LLC that are allowed to be sold on the market.


According to analysis, the primary considerations for FDA's PMTA review of e-cigarette products are the product's harm reduction and safety. Additionally, FDA favors closed and disposable e-cigarettes.


According to reports, NJOY is the third largest e-cigarette brand in the US and the only American e-cigarette company that has passed PMTA certification. Its ceramic chip is exclusively manufactured by SMIC. In July 2022, there were reports that Altria plans to acquire NJOY.


The PMTA has been approved for the following list:


List of products cleared by PMTA in 2021 | Image source: FDA official website


List of 2021 PMTA approvals | Image source: FDA official website


References:


1) Orders have been granted for premarket marketing of tobacco products.


As we reflect on the past year and anticipate the future, we examine the strides made by the FDA in regulating tobacco products in 2022.


Smoore, a leading vape manufacturer, has commented on the recent marketing orders issued by the US FDA. The company expressed flattery at being included in the targeted group for the orders. The FDA has ordered several companies to remove flavored vape products from the market due to concerns that they are targeting youth consumers. Smoore has stated that they will comply with the orders, but also voiced their desire to continue providing customers with quality products while ensuring the safety of all consumers.


E-cigarette maker NJOY is reportedly preparing for a possible sale.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

FDA Adds 18 Tobacco Harmful Constituents and Seeks Comment on 3 More
FDA Adds 18 Tobacco Harmful Constituents and Seeks Comment on 3 More
U.S. Food and Drug Administration published a Federal Register notice finalizing the addition of 18 constituents to the established list of Harmful and Potentially Harmful Constituents in tobacco products. With the update, the list now contains 111 constituents. FDA also proposed adding three more constituents to the list and opened a public comment period ending at 11:59 p.m. ET on May 26, 2026.
Apr.24 by 2FIRSTS.ai
New York’s Lawsuit Against Puff Bar and Other Flavored Vape Companies Survives Key Court Challenge
New York’s Lawsuit Against Puff Bar and Other Flavored Vape Companies Survives Key Court Challenge
According to Law360, a federal judge ruled that makers and distributors of flavored vape brands such as Puff Bar cannot escape New York’s lawsuit seeking to hold them responsible for the youth vaping epidemic. The court found that the state had adequately alleged the companies misrepresented how safe vaping is.
Apr.07 by 2FIRSTS.ai
2Firsts Hosts UK Vape Duty Stamp Compliance Exchange in Shenzhen
2Firsts Hosts UK Vape Duty Stamp Compliance Exchange in Shenzhen
2Firsts held a UK vape duty stamp compliance exchange in Shenzhen on May 14, bringing together representatives from nearly 20 companies. The session addressed Vaping Products Duty, duty stamp applications, UK agency qualifications and warehousing, while introducing 2Firsts Compliance Solutions’ UK service.
Events
May.17
Bangladesh May Remove E-Cigarette Production and Sales Ban in Tobacco Law Amendment
Bangladesh May Remove E-Cigarette Production and Sales Ban in Tobacco Law Amendment
Bangladesh is preparing amendments to its anti-tobacco ordinance that would remove the ban on the production and sale of e-cigarettes and also delete provisions prohibiting the display of tobacco products at points of sale.
Mar.31 by 2FIRSTS.ai
Al Fakher Parent AIR Advances U.S. Listing Plan, With Deal Expected in First Half of 2026
Al Fakher Parent AIR Advances U.S. Listing Plan, With Deal Expected in First Half of 2026
AIR Limited and Cantor Equity Partners III, Inc. announced that AIR and AIR Holdings Limited have filed a Form F-4 registration statement with the U.S. Securities and Exchange Commission in connection with their previously announced proposed business combination. Upon closing, the combined company, AIR Global PLC, is expected to be listed on Nasdaq in the United States under the ticker symbol “AIIR.”
Mar.31 by 2FIRSTS.ai
FDA nicotine pouch review delay report knocks tobacco shares lower
FDA nicotine pouch review delay report knocks tobacco shares lower
After Reuters reported before the market open that FDA reviews of nicotine pouch applications could face delays, shares of Philip Morris International, Turning Point Brands and British American Tobacco fell on April 1, underscoring the direct impact of U.S. regulatory signals on major tobacco companies and nicotine pouch expectations.
Apr.02